← Back to headlines
A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels…
26 Feb, 14:51 — 26 Feb, 14:51
The Story
Analyzing sources…
Source Diversity
Source Diversity
Low (19/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 1/5 buckets covered0/33
Far L
Left2
Left (2)
YahooBusiness Insider
Center
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Business InsiderMostly Factual164d ago
A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT). He said everyone should know 4 things before starting TRT. In 2020, longevity researcher Matt Kaeberlein started wondering if he had low testosterone levels. Then, in his early 50s, Kaeberlein had all the classic symptoms...
Read full article →YahooMostly Factual164d ago
A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Read full article →Coverage Timeline
First report: Yahoo · 26 Feb, 14:51|Full coverage: 2 · 0m|Window: 0m
Left-leaningCenterRight-leaning
